Emerging Treatment Strategies for Complex SFA Lesions

1391

[geoip-content country=”US, AF, DZ, AS, AO, AI, AQ, AG, AR, AW, AU, BS, BH, BD, BB, BZ, BJ, BM, BT, BO, BQ, BW, BV, BR, IO, BN, BF, BI, KH, CM, CA, CV, KY, CF, TD, CL, CN, CX, CC, CO, KM, CG, CD, CK, CR, CU, CW, CI, DJ, DM, DO, EC, EG, SV, GQ, ER, ET, FK, FO, FJ, GF, PF, TF, GA, GM, GH, GL, GD, GP, GU, GT, GG, GN, GW, GY, HT, HM, HN, HK, IN, ID, IR, IQ, IM, IL, JM, JP, JE, JO, KE, KI, KP, KR, KW, KG, LA, LB, LS, LR, LY, MO, MG, MW, MY, MV, ML, MT, MH, MQ, MR, MU, YT, MX, FM, MN, MS, MZ, MM, NA, NR, NP, NC, NZ, NI, NE, NG, NU, NF, MP, OM, PK, PW, PS, PA, PG, PY, PE, PH, PN, PR, QA, RW, RE, BL, SH, KN, LC, MF, PM, VC, WS, ST, SA, SN, SC, SL, SG, SX, SB, SO, ZA, GS, SS, LK, SD, SR, SJ, SZ, SY, TW, TJ, TZ, TH, TL, TG, TK, TO, TT, TN, TM, TC, TV, UG, AE, UM, UY, UZ, VU, VE, VN, VG, VI, WF, EH, YE, ZM, ZW, AX”]

This educational supplement is only available in countries in Europe.

[/geoip-content]

[geoip-content not_country=”US, AF, DZ, AS, AO, AI, AQ, AG, AR, AW, AU, BS, BH, BD, BB, BZ, BJ, BM, BT, BO, BQ, BW, BV, BR, IO, BN, BF, BI, KH, CM, CA, CV, KY, CF, TD, CL, CN, CX, CC, CO, KM, CG, CD, CK, CR, CU, CW, CI, DJ, DM, DO, EC, EG, SV, GQ, ER, ET, FK, FO, FJ, GF, PF, TF, GA, GM, GH, GL, GD, GP, GU, GT, GG, GN, GW, GY, HT, HM, HN, HK, IN, ID, IR, IQ, IM, IL, JM, JP, JE, JO, KE, KI, KP, KR, KW, KG, LA, LB, LS, LR, LY, MO, MG, MW, MY, MV, ML, MT, MH, MQ, MR, MU, YT, MX, FM, MN, MS, MZ, MM, NA, NR, NP, NC, NZ, NI, NE, NG, NU, NF, MP, OM, PK, PW, PS, PA, PG, PY, PE, PH, PN, PR, QA, RW, RE, BL, SH, KN, LC, MF, PM, VC, WS, ST, SA, SN, SC, SL, SG, SX, SB, SO, ZA, GS, SS, LK, SD, SR, SJ, SZ, SY, TW, TJ, TZ, TH, TL, TG, TK, TO, TT, TN, TM, TC, TV, UG, AE, UM, UY, UZ, VU, VE, VN, VG, VI, WF, EH, YE, ZM, ZW, AX”]

This educational supplement highlights how the combination of directional atherectomy (DA) with drug-coated balloon (DCB) angioplasty is transforming the treatment of complex superficial femoral artery (SFA) lesions in Europe. It also features a new SFA treatment algorithm that supports the use of DCB as a cornerstone of modern SFA treatment. Another key article underscores how science explains the difference between the mode of action of different DCB and contributes to the positive results obtained by Medtronic’s IN.PACT Admiral DCB vs. other devices such as Bard’s Lutonix.

Further, the supplement analyses the DEFINITIVE AR study and suggests that the combination treatment strategy of DA+DCB might be a solution for non-stent zones. It also examines the evidence backing DCB use in complex SFA lesions and contains some tips and tricks for those embarking on combination DA+DCB therapy for the first time.

[/geoip-content]